Search results
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Zacks via Yahoo Finance· 16 hours agoBio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased...
2seventy bio Inc (TSVT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and ...
GuruFocus.com via Yahoo Finance· 2 hours agoRelease Date: May 08, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points 2seventy bio Inc (NASDAQ:TSVT ...
Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook By Investing.com
Investing.com· 22 hours agoIn the first quarter of 2024, Bio-Rad Laboratories, Inc. (NYSE: NYSE:BIO) reported a decrease in net...
Bio-Rad Laboratories Maintains Full-Year Guide Despite Life Science Q1 Revenue Decline of 25 Percent
GenomeWeb News· 18 hours agoThis story has been updated to include additional information about Bio-Rad's Droplet Digital PCR initiatives. NEW YORK – Executives at Bio-Rad Laboratories ...
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
AOL· 1 day agoThe supplier of laboratory apparatus and instruments for drug manufacturers and biotech companies continues to see adjusted revenue growth for the full-year between 1% and 2.5% on a currency-neutral ...
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ...
WFRV 5 Green Bay· 21 hours agoBy rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality. NEW YORK, May 8, 2024 /PRNewswire ...
Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market Challenges
GuruFocus.com via Yahoo Finance· 1 day agoLife Science Segment: Experienced a significant sales decrease of 25.3% to $241.7 million,...
Annovis Bio, Inc. (NYSE:ANVS) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 1 day agoMerit Financial Group LLC decreased its holdings in Annovis Bio, Inc. (NYSE:ANVS – Free Report) by 46.1% in the fourth quarter, according to its most recent filing with the ...
Q1 2024 2Seventy Bio Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoParticipants Jenn Snyder; SVP, Corporate Affairs; 2Seventy Bio Inc Chip Baird; CEO; 2Seventy Bio Inc Vicki Eatwell; CFO; 2Seventy Bio ...
Understanding the Risks of Investing in Kronos Bio Inc
Knox Daily· 8 hours agoKronos Bio Inc’s recent filing unveils that its SR VP, CORP OPERATIONS & LEGAL Frisbee Allison unloaded Company’s shares for reported $12757.0 on Feb 21 ’24. In the deal valued ...
